Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents. Blesa, R, Toriyama, K, Ueda, K et al. Curr Alzheimer Res 2018PMID:29895249
Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation. Morenas-Rodríguez, E, Sala, I, Subirana, A et al. J. Alzheimers Dis. 2018PMID:29889064
A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes. Lleó, A, Irwin, DJ, Illán-Gala, I et al. JAMA Neurol 2018PMID:29554190
Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease. Cantero, JL, Atienza, M, Sanchez-Juan, P et al. Neurobiol. Aging 2018PMID:29331877
Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease. Jimenez, A, Pegueroles, J, Carmona-Iragui, M et al. Oncotarget 2017PMID:29285207
Synaptic phosphorylated α-synuclein in dementia with Lewy bodies. Colom-Cadena, M, Pegueroles, J, Herrmann, AG et al. Brain 2017PMID:29177427
Cortical microstructural changes along the Alzheimer's disease continuum. Montal, V, Vilaplana, E, Alcolea, D et al. Alzheimers Dement 2018PMID:29080407
Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the C9orf72 expansion mutation. Dols-Icardo, O, García-Redondo, A, Rojas-García, R et al. J. Neurol. Neurosurg. Psychiatry 2018PMID:28889094
YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer's disease and other tauopathies. Querol-Vilaseca, M, Colom-Cadena, M, Pegueroles, J et al. J Neuroinflammation 2017PMID:28599675
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Alcolea, D, Vilaplana, E, Suárez-Calvet, M et al. Neurology 2017PMID:28592456
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease. Sala, I, Illán-Gala, I, Alcolea, D et al. J. Alzheimers Dis. 2017PMID:28527215
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease. Carmona-Iragui, M, Balasa, M, Benejam, B et al. Alzheimers Dement 2017PMID:28463681
Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum. Cervera-Carles, L, Alcolea, D, Estanga, A et al. Neurobiol. Aging 2017PMID:28089353
Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome. Carmona-Iragui, M, Santos, T, Videla, S et al. J. Alzheimers Dis. 2017PMID:27858714
Longitudinal brain structural changes in preclinical Alzheimer's disease. Pegueroles, J, Vilaplana, E, Montal, V et al. Alzheimers Dement 2017PMID:27693189
Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases. Parnetti, L, Eusebi, P, Lleó, A et al. Front Neurol Neurosci 2016PMID:27463974
Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias. Morenas-Rodríguez, E, Cervera-Carles, L, Vilaplana, E et al. J. Alzheimers Dis. 2016PMID:26682689
Assessing the role of TUBA4A gene in frontotemporal degeneration. Dols-Icardo, O, Iborra, O, Valdivia, J et al. Neurobiol. Aging 2016PMID:26675813
Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation. Carmona-Iragui, M, Fernández-Arcos, A, Alcolea, D et al. J. Alzheimers Dis. 2016PMID:26639966
Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases. Cervera-Carles, L, Pagonabarraga, J, Pascual-Sedano, B et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2016PMID:26453547
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
